
Photo from Pashtoon Kasi/X
Apr 3, 2024, 06:35
Pashtoon Kasi: ctDNA kinetics is going to be an important variable to look at in patients getting novel immunotherapy drugs like the BOT/BAL on our NEST trial
Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X/Twitter:
”ctDNA kineticsis going to be an important variable to look at in patients getting novel immunotherapy drugs like the BOT/BAL on our NEST trial. The longer you let it brew, the deeper the drop eventual clearance. 100 post-operation. March is Colorectal Cancer Awareness Month.”
Source: Pashtoon Kasi/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10
Feb 22, 2025, 13:04
Feb 22, 2025, 11:28
Feb 22, 2025, 11:22
Feb 22, 2025, 11:15
Feb 22, 2025, 11:02
Feb 22, 2025, 10:47